| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/01/2010 | EP2223938A1 Derivatives of exendin |
| 09/01/2010 | EP2223935A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/01/2010 | EP2223934A1 Methods for inhibiting influenza virus infection and their drugs |
| 09/01/2010 | EP2223932A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 09/01/2010 | EP2223701A1 Pharmaceutical composition for cancer treatment |
| 09/01/2010 | EP2223699A1 Radical therapeutic agent for keloid and hypertrophic scar |
| 09/01/2010 | EP2223698A1 Platelet-derived growth factor compositions and method of use thereof |
| 09/01/2010 | EP2223684A2 Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof |
| 09/01/2010 | EP2222699A1 Use of fzc18-containing collagen 18 polypeptides for the treatment, diagnosis and outcome prediction of diseases |
| 09/01/2010 | EP2222696A1 Bmp mutants with decreased susceptibility to noggin |
| 09/01/2010 | EP2222330A1 Treatment of inflammatory illnesses with ace2 |
| 09/01/2010 | EP2222329A1 Modified recombinant factor viii and von willebrand factor and methods of use |
| 09/01/2010 | EP2222328A1 Method of administering conjugates |
| 09/01/2010 | EP2222327A2 Topical application and formulation of erythropoietin for skin wound healing |
| 09/01/2010 | EP2222326A2 Inhibitors of malt1 proteolytic activity and uses thereof |
| 09/01/2010 | EP2222325A2 Compositions for reducing oxidative stress and uses thereof |
| 09/01/2010 | EP2222324A2 Boceprevir derivatives for the treatment of hcv infections |
| 09/01/2010 | EP2222315A1 Stabilized factor ix formulations containing trehalose |
| 09/01/2010 | EP1709047B1 Azabenzofuran substituted thioureas as inhibitors of viral replication |
| 09/01/2010 | EP1669367B1 Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 09/01/2010 | EP1606409B1 Nogo receptor binding protein |
| 09/01/2010 | EP1549672B1 Ablated slam-dependent cell entry |
| 09/01/2010 | EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/01/2010 | EP1408117B1 Glycoprotein and process for producing the same |
| 09/01/2010 | EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 09/01/2010 | EP1207905B1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/01/2010 | EP1028942B1 Dipeptide nitriles |
| 09/01/2010 | CN1995065B Fusion protein for suppressing PTTG expression and its coding gene and uses |
| 09/01/2010 | CN1904036B Method of producing three kinds of human alpha alexins by gene engineering bacteria mixed culture |
| 09/01/2010 | CN1903876B Polypeptide, nucleic acid molecule coding it and use |
| 09/01/2010 | CN1852665B Infant formula |
| 09/01/2010 | CN1523997B Stabilized interleukin 2 |
| 09/01/2010 | CN101821403A Cell for use in the production of exogenous protein, and production process using the cell |
| 09/01/2010 | CN101821287A Interferon fusion proteins |
| 09/01/2010 | CN101820917A Aqueous ophthalmic formulations |
| 09/01/2010 | CN101820897A Cytoplasmic malate dehydrogenase (MDH1) targeted treatment for neurodegenerative diseases |
| 09/01/2010 | CN101820896A IGF for the treatment of rett syndrome and synaptic disorders |
| 09/01/2010 | CN101820895A Compositions and methods for treating the vertebral column |
| 09/01/2010 | CN101820894A VHZ for diagnosis and treatment of cancer |
| 09/01/2010 | CN101820887A Controlled release interferon drug products and treatment of hcv infection using sam |
| 09/01/2010 | CN101820756A Protein kinase c-d inhibitors that protect against cellular injury and inflammation and promote astrocyte proliferation |
| 09/01/2010 | CN101818138A Method for the production of GLA-residue containing serine proteases |
| 09/01/2010 | CN101818137A Method for the production of gla-residue containing serine proteases |
| 09/01/2010 | CN101817883A Housefly cecropin-human lysozyme fusion protein, and preparation method and application thereof |
| 09/01/2010 | CN101817878A Monomer quick-acting insulin as well as preparing method and application thereof |
| 09/01/2010 | CN101817877A Active fragment of anti-opioid peptide |
| 09/01/2010 | CN101817872A Orally administered peptides synergize statin activity |
| 09/01/2010 | CN101817871A Edwardsiella tarda quorum sensing blocking factor, construction and application thereof |
| 09/01/2010 | CN101816790A Spray for treating radioactive xerostomia and preparation method thereof |
| 09/01/2010 | CN101816788A Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/01/2010 | CN101816782A Composite enzyme apophlegmatisant |
| 09/01/2010 | CN101816781A Gene recombinant human Cu-Zn superoxide dismutase liposome enteric-coated capsule and preparation method thereof |
| 09/01/2010 | CN101816780A Injectable bone growth factor-carrying microspheres and preparation method thereof |
| 09/01/2010 | CN101816779A Human nuclear clusterin, vector and application thereof |
| 09/01/2010 | CN101816778A Whey protein pre-load |
| 09/01/2010 | CN101816777A Novel Boanmycin composition and preparation method thereof |
| 09/01/2010 | CN101816705A Medicine for treating femoral head necrosis by three-needle injection and fumigation and preparation method thereof |
| 09/01/2010 | CN101816634A Technology for preparing bone growth factor carrying microsphere by using ultrasonic atomization method |
| 09/01/2010 | CN101816630A Uricase lipid nanoparticle and preparation method thereof |
| 09/01/2010 | CN101301274B Compound mequindox soluble powder for animals and preparation thereof |
| 09/01/2010 | CN101297672B Method for producing active peptides from enzymolysis of fish proteins using active enzymes in angleworm intestinal canal |
| 09/01/2010 | CN101245098B Antimicrobial antiphlogistic antagonism polypeptide simulating MD2 |
| 09/01/2010 | CN101081865B Abstraction of pilose antler releasing somatomedin (DEER GHRF) and preparation method thereof |
| 09/01/2010 | CN101077193B Sheep milk fat and its production method and application |
| 09/01/2010 | CN101054409B Amphiphilic short peptide and use thereof |
| 08/31/2010 | US7786352 Methods for the production of apolipoproteins in transgenic plants |
| 08/31/2010 | US7786321 Compounds of the N-acylamino amide family compositions comprising them and uses thereof |
| 08/31/2010 | US7786286 Microorganismal, outer-membrane, enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection |
| 08/31/2010 | US7786282 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 08/31/2010 | US7786271 Antibodies that inhibit TSLP activity |
| 08/31/2010 | US7786268 Anti-IP-10 antibodies and methods of use thereof |
| 08/31/2010 | US7786265 Modulation of body weights; dietetics; eating disorders; for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass |
| 08/31/2010 | US7786264 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof |
| 08/31/2010 | US7786262 Low density lipoprotein receptor fusion for use in prevention and treatment of inflammation and autoimmune diseases |
| 08/31/2010 | US7786261 protein of an ectodomain of a transforming growth factor beta membrane-bound receptor and a peptide subunit of an alpha -helical coiled-coil; selecting compounds capable of inhibiting ligand binding and kinase activity |
| 08/31/2010 | US7786258 Methods for inhibiting immune complex formation in a subject |
| 08/31/2010 | US7786257 Lymphocyte receptors peptide for use as tool in prevention and treatment of infection, autoimmune and cell proliferative disorders; mimetics |
| 08/31/2010 | US7786170 synergistic; Tumor necrosis factor related apoptosis inducing ligand and LAQ824 (N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide) Dacinostat, which augments Apo-2L/TRAIL-induced DISC (death inducing signaling complex) and apoptosis of human acute leukemia cells |
| 08/31/2010 | US7786166 Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agent |
| 08/31/2010 | US7786103 Method for isolating an intestinal cholesterol binding protein |
| 08/31/2010 | US7786096 Inhibition of antigen presentation with poorly catabolized polymers |
| 08/31/2010 | US7786088 Targeting vector to the urokinase plasminogen activator receptor |
| 08/31/2010 | US7786086 at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody |
| 08/31/2010 | US7786085 Method for treating a patient undergoing chemotherapy |
| 08/31/2010 | US7786084 Treatment of burns |
| 08/31/2010 | US7786083 Metastin derivatives and use thereof |
| 08/31/2010 | US7786082 Combinations of human proteins to enhance in vivo viability of stem cells and progenitor cells |
| 08/31/2010 | US7786081 Peptide composition |
| 08/31/2010 | US7786080 wild type protein; leucine in the wild type protein at the amino acid position 51 of human BMP-2 is substituted by proline in the mutein; biodrugs for treating fibrotic diseases, wound healing, hypervascularization, vascular diseases, fractures, and osteoporosis |
| 08/31/2010 | US7786079 Substituted nonadepsipeptides |
| 08/31/2010 | US7786078 cyclic polypeptides; inhibitor of chemokine receptors; biodrugs as antiinflammatory agent, anticarcinogenic agent; preventing HIV infections; drug target |
| 08/31/2010 | US7786077 Insulins combinations |
| 08/31/2010 | US7786076 Immunogenic compositions and methods of use |
| 08/31/2010 | US7785887 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes |
| 08/31/2010 | US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease |
| 08/31/2010 | US7785881 MAGE-C2 antigenic peptides and uses thereof |
| 08/31/2010 | US7785878 Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof |
| 08/31/2010 | US7785873 Antigen arrays for treatment of bone disease |
| 08/31/2010 | US7785870 Cell-specific expression/replication vector |
| 08/31/2010 | US7785856 therapeutic fusion protein comprising amino acid residues 70-952 of human acid alpha-glucosidase (GAA) and a peptide tag; permits M6P-independent targeting of human GAA or GAA-like enzymes to patient lysosomes |